In a presentation for the psychedelics track at Cannabis Science Conference East 2022, Janie Maedler, Vice President of Rylie’s Smile Foundation and President of Rylie’s Sunshine LLC, led a panel discussion with Rylie Maedler, President of Rylie’s Smile and CEO of Rylie’s Sunshine LLC; Rita Lynn Lawrence, a cannabis patient advocate; and University of Miami cannabis epidemiologist Dr. Denise Vidot. The presentation titled “Psychedelics for Beginners” discussed the basics of using psychedelics for treating mental health issues safely and successfully. Here are some highlights from the session.
On day two of the psychedelics track at Cannabis Science Conference East, Janie Maedler, Vice President of Rylie’s Smile Foundation, President of Rylie’s Sunshine LLC, and mother of three, led a panel discussion that provided a space to hear others’ stories for those new to psychedelics and also gave a presentation on harm reduction techniques. Maedler gave an overview of her family’s preparation, both physically and mentally, for psychedelics and then asked several questions of the panel such as:
Each panelist told her own story of how she began her psychedelics journey, the research and planning done, who they sought for assistance, and their results and reflections. Dr. Denise Vidot explained her approach as a scientist and analyst; Rita Lynn Lawrence shared how she ensured a safe and positive first journey; and Rylie Maedler provided a pediatric perspective and explained the guidance given to her and her brother by their mother. One common theme in all three stories was how medical cannabis led them to psychedelics.
The overall takeaways from the presentation, Janie Maedler noted, were the goals of harm reduction—noting a helpful app on drug combinations and promoting at-home drug testing kits—and of reflection after each experience with psychedelics. One of the responses from the audience reaffirmed the importance continuously sharing and hearing each others’ stories, especially coming from those who are first in a field.
Read more on Rylie’s Smile and Rylie’s Sunshine in this interview with Cannabis Science and Technology: https://www.cannabissciencetech.com/view/inspiration-move-me-brightly-a-closer-look-at-the-rylie-s-sunshine-journey-led-by-the-youngest-ceo-in-cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Khan
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.